Medical Care
mRNA Vaccine Core Enzyme- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
- Jul 14, 25
- ID: 374878
- Pages: 126
- Figures: 128
- Views: 13
The global market for mRNA Vaccine Core Enzyme was estimated to be worth US$ 2008 million in 2024 and is forecast to a readjusted size of US$ 1687 million by 2031 with a CAGR of -2.5% during the forecast period 2025-2031.
mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development. mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs.
The core manufacturers of mRNA Vaccine Core Enzyme mainly include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, etc. The top four companies in the industry account for about 49% of the market. North America is the largest market, accounting for about 38% of the global market share. In terms of product type, Capping Enzyme have the largest market share of about 25%. From an application perspective, Biopharmaceutical Companies account for the largest share at around 84%.
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccine Core Enzyme, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of mRNA Vaccine Core Enzyme by region & country, by Enzyme Type, and by Application.
The mRNA Vaccine Core Enzyme market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccine Core Enzyme.
Market Segmentation
By Company
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology
Segment by Enzyme Type
Capping Enzyme
2'-O-Methyltransferase
Inorganic Pyrophosphatase
Poly (A) Polymerase
Rnase Inhibitor
RNA Polymerase
Restriction Enzyme
Dnase I
Others
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutions
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of mRNA Vaccine Core Enzyme manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Enzyme Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of mRNA Vaccine Core Enzyme in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of mRNA Vaccine Core Enzyme in country level. It provides sigmate data by Enzyme Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development. mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs.
The core manufacturers of mRNA Vaccine Core Enzyme mainly include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, etc. The top four companies in the industry account for about 49% of the market. North America is the largest market, accounting for about 38% of the global market share. In terms of product type, Capping Enzyme have the largest market share of about 25%. From an application perspective, Biopharmaceutical Companies account for the largest share at around 84%.
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccine Core Enzyme, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of mRNA Vaccine Core Enzyme by region & country, by Enzyme Type, and by Application.
The mRNA Vaccine Core Enzyme market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccine Core Enzyme.
Market Segmentation
By Company
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology
Segment by Enzyme Type
Capping Enzyme
2'-O-Methyltransferase
Inorganic Pyrophosphatase
Poly (A) Polymerase
Rnase Inhibitor
RNA Polymerase
Restriction Enzyme
Dnase I
Others
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutions
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of mRNA Vaccine Core Enzyme manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Enzyme Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of mRNA Vaccine Core Enzyme in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of mRNA Vaccine Core Enzyme in country level. It provides sigmate data by Enzyme Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 mRNA Vaccine Core Enzyme Product Introduction
1.2 Global mRNA Vaccine Core Enzyme Market Size Forecast
1.2.1 Global mRNA Vaccine Core Enzyme Sales Value (2020-2031)
1.2.2 Global mRNA Vaccine Core Enzyme Sales Volume (2020-2031)
1.2.3 Global mRNA Vaccine Core Enzyme Sales Price (2020-2031)
1.3 mRNA Vaccine Core Enzyme Market Trends & Drivers
1.3.1 mRNA Vaccine Core Enzyme Industry Trends
1.3.2 mRNA Vaccine Core Enzyme Market Drivers & Opportunity
1.3.3 mRNA Vaccine Core Enzyme Market Challenges
1.3.4 mRNA Vaccine Core Enzyme Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global mRNA Vaccine Core Enzyme Players Revenue Ranking (2024)
2.2 Global mRNA Vaccine Core Enzyme Revenue by Company (2020-2025)
2.3 Global mRNA Vaccine Core Enzyme Players Sales Volume Ranking (2024)
2.4 Global mRNA Vaccine Core Enzyme Sales Volume by Company Players (2020-2025)
2.5 Global mRNA Vaccine Core Enzyme Average Price by Company (2020-2025)
2.6 Key Manufacturers mRNA Vaccine Core Enzyme Manufacturing Base and Headquarters
2.7 Key Manufacturers mRNA Vaccine Core Enzyme Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of mRNA Vaccine Core Enzyme
2.9 mRNA Vaccine Core Enzyme Market Competitive Analysis
2.9.1 mRNA Vaccine Core Enzyme Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by mRNA Vaccine Core Enzyme Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine Core Enzyme as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Enzyme Type
3.1 Introduction by Enzyme Type
3.1.1 Capping Enzyme
3.1.2 2'-O-Methyltransferase
3.1.3 Inorganic Pyrophosphatase
3.1.4 Poly (A) Polymerase
3.1.5 Rnase Inhibitor
3.1.6 RNA Polymerase
3.1.7 Restriction Enzyme
3.1.8 Dnase I
3.1.9 Others
3.2 Global mRNA Vaccine Core Enzyme Sales Value by Enzyme Type
3.2.1 Global mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (2020 VS 2024 VS 2031)
3.2.2 Global mRNA Vaccine Core Enzyme Sales Value, by Enzyme Type (2020-2031)
3.2.3 Global mRNA Vaccine Core Enzyme Sales Value, by Enzyme Type (%) (2020-2031)
3.3 Global mRNA Vaccine Core Enzyme Sales Volume by Enzyme Type
3.3.1 Global mRNA Vaccine Core Enzyme Sales Volume by Enzyme Type (2020 VS 2024 VS 2031)
3.3.2 Global mRNA Vaccine Core Enzyme Sales Volume, by Enzyme Type (2020-2031)
3.3.3 Global mRNA Vaccine Core Enzyme Sales Volume, by Enzyme Type (%) (2020-2031)
3.4 Global mRNA Vaccine Core Enzyme Average Price by Enzyme Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biopharmaceutical Companies
4.1.2 Academic and Research Institutions
4.2 Global mRNA Vaccine Core Enzyme Sales Value by Application
4.2.1 Global mRNA Vaccine Core Enzyme Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global mRNA Vaccine Core Enzyme Sales Value, by Application (2020-2031)
4.2.3 Global mRNA Vaccine Core Enzyme Sales Value, by Application (%) (2020-2031)
4.3 Global mRNA Vaccine Core Enzyme Sales Volume by Application
4.3.1 Global mRNA Vaccine Core Enzyme Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global mRNA Vaccine Core Enzyme Sales Volume, by Application (2020-2031)
4.3.3 Global mRNA Vaccine Core Enzyme Sales Volume, by Application (%) (2020-2031)
4.4 Global mRNA Vaccine Core Enzyme Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global mRNA Vaccine Core Enzyme Sales Value by Region
5.1.1 Global mRNA Vaccine Core Enzyme Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global mRNA Vaccine Core Enzyme Sales Value by Region (2020-2025)
5.1.3 Global mRNA Vaccine Core Enzyme Sales Value by Region (2026-2031)
5.1.4 Global mRNA Vaccine Core Enzyme Sales Value by Region (%), (2020-2031)
5.2 Global mRNA Vaccine Core Enzyme Sales Volume by Region
5.2.1 Global mRNA Vaccine Core Enzyme Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global mRNA Vaccine Core Enzyme Sales Volume by Region (2020-2025)
5.2.3 Global mRNA Vaccine Core Enzyme Sales Volume by Region (2026-2031)
5.2.4 Global mRNA Vaccine Core Enzyme Sales Volume by Region (%), (2020-2031)
5.3 Global mRNA Vaccine Core Enzyme Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America mRNA Vaccine Core Enzyme Sales Value, 2020-2031
5.4.2 North America mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe mRNA Vaccine Core Enzyme Sales Value, 2020-2031
5.5.2 Europe mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific mRNA Vaccine Core Enzyme Sales Value, 2020-2031
5.6.2 Asia Pacific mRNA Vaccine Core Enzyme Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America mRNA Vaccine Core Enzyme Sales Value, 2020-2031
5.7.2 South America mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa mRNA Vaccine Core Enzyme Sales Value, 2020-2031
5.8.2 Middle East & Africa mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions mRNA Vaccine Core Enzyme Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions mRNA Vaccine Core Enzyme Sales Value
6.2.1 Key Countries/Regions mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.2.2 Key Countries/Regions mRNA Vaccine Core Enzyme Sales Volume, 2020-2031
6.3 United States
6.3.1 United States mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.3.2 United States mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
6.3.3 United States mRNA Vaccine Core Enzyme Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.4.2 Europe mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
6.4.3 Europe mRNA Vaccine Core Enzyme Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.5.2 China mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
6.5.3 China mRNA Vaccine Core Enzyme Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.6.2 Japan mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
6.6.3 Japan mRNA Vaccine Core Enzyme Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.7.2 South Korea mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
6.7.3 South Korea mRNA Vaccine Core Enzyme Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.8.2 Southeast Asia mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
6.8.3 Southeast Asia mRNA Vaccine Core Enzyme Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.9.2 India mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
6.9.3 India mRNA Vaccine Core Enzyme Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Information
7.1.2 Thermo Fisher Introduction and Business Overview
7.1.3 Thermo Fisher mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Thermo Fisher mRNA Vaccine Core Enzyme Product Offerings
7.1.5 Thermo Fisher Recent Development
7.2 NEB
7.2.1 NEB Company Information
7.2.2 NEB Introduction and Business Overview
7.2.3 NEB mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 NEB mRNA Vaccine Core Enzyme Product Offerings
7.2.5 NEB Recent Development
7.3 TriLink Bio Technologies
7.3.1 TriLink Bio Technologies Company Information
7.3.2 TriLink Bio Technologies Introduction and Business Overview
7.3.3 TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 TriLink Bio Technologies mRNA Vaccine Core Enzyme Product Offerings
7.3.5 TriLink Bio Technologies Recent Development
7.4 Merck
7.4.1 Merck Company Information
7.4.2 Merck Introduction and Business Overview
7.4.3 Merck mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Merck mRNA Vaccine Core Enzyme Product Offerings
7.4.5 Merck Recent Development
7.5 Aldevron
7.5.1 Aldevron Company Information
7.5.2 Aldevron Introduction and Business Overview
7.5.3 Aldevron mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Aldevron mRNA Vaccine Core Enzyme Product Offerings
7.5.5 Aldevron Recent Development
7.6 Qiagen N.V.
7.6.1 Qiagen N.V. Company Information
7.6.2 Qiagen N.V. Introduction and Business Overview
7.6.3 Qiagen N.V. mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Qiagen N.V. mRNA Vaccine Core Enzyme Product Offerings
7.6.5 Qiagen N.V. Recent Development
7.7 Promega
7.7.1 Promega Company Information
7.7.2 Promega Introduction and Business Overview
7.7.3 Promega mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Promega mRNA Vaccine Core Enzyme Product Offerings
7.7.5 Promega Recent Development
7.8 Roche CustomBiotech
7.8.1 Roche CustomBiotech Company Information
7.8.2 Roche CustomBiotech Introduction and Business Overview
7.8.3 Roche CustomBiotech mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Roche CustomBiotech mRNA Vaccine Core Enzyme Product Offerings
7.8.5 Roche CustomBiotech Recent Development
7.9 Takara Bio Inc.
7.9.1 Takara Bio Inc. Company Information
7.9.2 Takara Bio Inc. Introduction and Business Overview
7.9.3 Takara Bio Inc. mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Takara Bio Inc. mRNA Vaccine Core Enzyme Product Offerings
7.9.5 Takara Bio Inc. Recent Development
7.10 Novoprotein
7.10.1 Novoprotein Company Information
7.10.2 Novoprotein Introduction and Business Overview
7.10.3 Novoprotein mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Novoprotein mRNA Vaccine Core Enzyme Product Offerings
7.10.5 Novoprotein Recent Development
7.11 Vazyme
7.11.1 Vazyme Company Information
7.11.2 Vazyme Introduction and Business Overview
7.11.3 Vazyme mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Vazyme mRNA Vaccine Core Enzyme Product Offerings
7.11.5 Vazyme Recent Development
7.12 Hongene Biotech Corporatio
7.12.1 Hongene Biotech Corporatio Company Information
7.12.2 Hongene Biotech Corporatio Introduction and Business Overview
7.12.3 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product Offerings
7.12.5 Hongene Biotech Corporatio Recent Development
7.13 Yeasen Biotechnology
7.13.1 Yeasen Biotechnology Company Information
7.13.2 Yeasen Biotechnology Introduction and Business Overview
7.13.3 Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Yeasen Biotechnology mRNA Vaccine Core Enzyme Product Offerings
7.13.5 Yeasen Biotechnology Recent Development
8 Industry Chain Analysis
8.1 mRNA Vaccine Core Enzyme Industrial Chain
8.2 mRNA Vaccine Core Enzyme Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 mRNA Vaccine Core Enzyme Sales Model
8.5.2 Sales Channel
8.5.3 mRNA Vaccine Core Enzyme Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 mRNA Vaccine Core Enzyme Product Introduction
1.2 Global mRNA Vaccine Core Enzyme Market Size Forecast
1.2.1 Global mRNA Vaccine Core Enzyme Sales Value (2020-2031)
1.2.2 Global mRNA Vaccine Core Enzyme Sales Volume (2020-2031)
1.2.3 Global mRNA Vaccine Core Enzyme Sales Price (2020-2031)
1.3 mRNA Vaccine Core Enzyme Market Trends & Drivers
1.3.1 mRNA Vaccine Core Enzyme Industry Trends
1.3.2 mRNA Vaccine Core Enzyme Market Drivers & Opportunity
1.3.3 mRNA Vaccine Core Enzyme Market Challenges
1.3.4 mRNA Vaccine Core Enzyme Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global mRNA Vaccine Core Enzyme Players Revenue Ranking (2024)
2.2 Global mRNA Vaccine Core Enzyme Revenue by Company (2020-2025)
2.3 Global mRNA Vaccine Core Enzyme Players Sales Volume Ranking (2024)
2.4 Global mRNA Vaccine Core Enzyme Sales Volume by Company Players (2020-2025)
2.5 Global mRNA Vaccine Core Enzyme Average Price by Company (2020-2025)
2.6 Key Manufacturers mRNA Vaccine Core Enzyme Manufacturing Base and Headquarters
2.7 Key Manufacturers mRNA Vaccine Core Enzyme Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of mRNA Vaccine Core Enzyme
2.9 mRNA Vaccine Core Enzyme Market Competitive Analysis
2.9.1 mRNA Vaccine Core Enzyme Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by mRNA Vaccine Core Enzyme Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine Core Enzyme as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Enzyme Type
3.1 Introduction by Enzyme Type
3.1.1 Capping Enzyme
3.1.2 2'-O-Methyltransferase
3.1.3 Inorganic Pyrophosphatase
3.1.4 Poly (A) Polymerase
3.1.5 Rnase Inhibitor
3.1.6 RNA Polymerase
3.1.7 Restriction Enzyme
3.1.8 Dnase I
3.1.9 Others
3.2 Global mRNA Vaccine Core Enzyme Sales Value by Enzyme Type
3.2.1 Global mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (2020 VS 2024 VS 2031)
3.2.2 Global mRNA Vaccine Core Enzyme Sales Value, by Enzyme Type (2020-2031)
3.2.3 Global mRNA Vaccine Core Enzyme Sales Value, by Enzyme Type (%) (2020-2031)
3.3 Global mRNA Vaccine Core Enzyme Sales Volume by Enzyme Type
3.3.1 Global mRNA Vaccine Core Enzyme Sales Volume by Enzyme Type (2020 VS 2024 VS 2031)
3.3.2 Global mRNA Vaccine Core Enzyme Sales Volume, by Enzyme Type (2020-2031)
3.3.3 Global mRNA Vaccine Core Enzyme Sales Volume, by Enzyme Type (%) (2020-2031)
3.4 Global mRNA Vaccine Core Enzyme Average Price by Enzyme Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biopharmaceutical Companies
4.1.2 Academic and Research Institutions
4.2 Global mRNA Vaccine Core Enzyme Sales Value by Application
4.2.1 Global mRNA Vaccine Core Enzyme Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global mRNA Vaccine Core Enzyme Sales Value, by Application (2020-2031)
4.2.3 Global mRNA Vaccine Core Enzyme Sales Value, by Application (%) (2020-2031)
4.3 Global mRNA Vaccine Core Enzyme Sales Volume by Application
4.3.1 Global mRNA Vaccine Core Enzyme Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global mRNA Vaccine Core Enzyme Sales Volume, by Application (2020-2031)
4.3.3 Global mRNA Vaccine Core Enzyme Sales Volume, by Application (%) (2020-2031)
4.4 Global mRNA Vaccine Core Enzyme Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global mRNA Vaccine Core Enzyme Sales Value by Region
5.1.1 Global mRNA Vaccine Core Enzyme Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global mRNA Vaccine Core Enzyme Sales Value by Region (2020-2025)
5.1.3 Global mRNA Vaccine Core Enzyme Sales Value by Region (2026-2031)
5.1.4 Global mRNA Vaccine Core Enzyme Sales Value by Region (%), (2020-2031)
5.2 Global mRNA Vaccine Core Enzyme Sales Volume by Region
5.2.1 Global mRNA Vaccine Core Enzyme Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global mRNA Vaccine Core Enzyme Sales Volume by Region (2020-2025)
5.2.3 Global mRNA Vaccine Core Enzyme Sales Volume by Region (2026-2031)
5.2.4 Global mRNA Vaccine Core Enzyme Sales Volume by Region (%), (2020-2031)
5.3 Global mRNA Vaccine Core Enzyme Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America mRNA Vaccine Core Enzyme Sales Value, 2020-2031
5.4.2 North America mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe mRNA Vaccine Core Enzyme Sales Value, 2020-2031
5.5.2 Europe mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific mRNA Vaccine Core Enzyme Sales Value, 2020-2031
5.6.2 Asia Pacific mRNA Vaccine Core Enzyme Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America mRNA Vaccine Core Enzyme Sales Value, 2020-2031
5.7.2 South America mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa mRNA Vaccine Core Enzyme Sales Value, 2020-2031
5.8.2 Middle East & Africa mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions mRNA Vaccine Core Enzyme Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions mRNA Vaccine Core Enzyme Sales Value
6.2.1 Key Countries/Regions mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.2.2 Key Countries/Regions mRNA Vaccine Core Enzyme Sales Volume, 2020-2031
6.3 United States
6.3.1 United States mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.3.2 United States mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
6.3.3 United States mRNA Vaccine Core Enzyme Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.4.2 Europe mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
6.4.3 Europe mRNA Vaccine Core Enzyme Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.5.2 China mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
6.5.3 China mRNA Vaccine Core Enzyme Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.6.2 Japan mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
6.6.3 Japan mRNA Vaccine Core Enzyme Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.7.2 South Korea mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
6.7.3 South Korea mRNA Vaccine Core Enzyme Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.8.2 Southeast Asia mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
6.8.3 Southeast Asia mRNA Vaccine Core Enzyme Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India mRNA Vaccine Core Enzyme Sales Value, 2020-2031
6.9.2 India mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
6.9.3 India mRNA Vaccine Core Enzyme Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Information
7.1.2 Thermo Fisher Introduction and Business Overview
7.1.3 Thermo Fisher mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Thermo Fisher mRNA Vaccine Core Enzyme Product Offerings
7.1.5 Thermo Fisher Recent Development
7.2 NEB
7.2.1 NEB Company Information
7.2.2 NEB Introduction and Business Overview
7.2.3 NEB mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 NEB mRNA Vaccine Core Enzyme Product Offerings
7.2.5 NEB Recent Development
7.3 TriLink Bio Technologies
7.3.1 TriLink Bio Technologies Company Information
7.3.2 TriLink Bio Technologies Introduction and Business Overview
7.3.3 TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 TriLink Bio Technologies mRNA Vaccine Core Enzyme Product Offerings
7.3.5 TriLink Bio Technologies Recent Development
7.4 Merck
7.4.1 Merck Company Information
7.4.2 Merck Introduction and Business Overview
7.4.3 Merck mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Merck mRNA Vaccine Core Enzyme Product Offerings
7.4.5 Merck Recent Development
7.5 Aldevron
7.5.1 Aldevron Company Information
7.5.2 Aldevron Introduction and Business Overview
7.5.3 Aldevron mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Aldevron mRNA Vaccine Core Enzyme Product Offerings
7.5.5 Aldevron Recent Development
7.6 Qiagen N.V.
7.6.1 Qiagen N.V. Company Information
7.6.2 Qiagen N.V. Introduction and Business Overview
7.6.3 Qiagen N.V. mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Qiagen N.V. mRNA Vaccine Core Enzyme Product Offerings
7.6.5 Qiagen N.V. Recent Development
7.7 Promega
7.7.1 Promega Company Information
7.7.2 Promega Introduction and Business Overview
7.7.3 Promega mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Promega mRNA Vaccine Core Enzyme Product Offerings
7.7.5 Promega Recent Development
7.8 Roche CustomBiotech
7.8.1 Roche CustomBiotech Company Information
7.8.2 Roche CustomBiotech Introduction and Business Overview
7.8.3 Roche CustomBiotech mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Roche CustomBiotech mRNA Vaccine Core Enzyme Product Offerings
7.8.5 Roche CustomBiotech Recent Development
7.9 Takara Bio Inc.
7.9.1 Takara Bio Inc. Company Information
7.9.2 Takara Bio Inc. Introduction and Business Overview
7.9.3 Takara Bio Inc. mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Takara Bio Inc. mRNA Vaccine Core Enzyme Product Offerings
7.9.5 Takara Bio Inc. Recent Development
7.10 Novoprotein
7.10.1 Novoprotein Company Information
7.10.2 Novoprotein Introduction and Business Overview
7.10.3 Novoprotein mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Novoprotein mRNA Vaccine Core Enzyme Product Offerings
7.10.5 Novoprotein Recent Development
7.11 Vazyme
7.11.1 Vazyme Company Information
7.11.2 Vazyme Introduction and Business Overview
7.11.3 Vazyme mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Vazyme mRNA Vaccine Core Enzyme Product Offerings
7.11.5 Vazyme Recent Development
7.12 Hongene Biotech Corporatio
7.12.1 Hongene Biotech Corporatio Company Information
7.12.2 Hongene Biotech Corporatio Introduction and Business Overview
7.12.3 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product Offerings
7.12.5 Hongene Biotech Corporatio Recent Development
7.13 Yeasen Biotechnology
7.13.1 Yeasen Biotechnology Company Information
7.13.2 Yeasen Biotechnology Introduction and Business Overview
7.13.3 Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Yeasen Biotechnology mRNA Vaccine Core Enzyme Product Offerings
7.13.5 Yeasen Biotechnology Recent Development
8 Industry Chain Analysis
8.1 mRNA Vaccine Core Enzyme Industrial Chain
8.2 mRNA Vaccine Core Enzyme Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 mRNA Vaccine Core Enzyme Sales Model
8.5.2 Sales Channel
8.5.3 mRNA Vaccine Core Enzyme Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. mRNA Vaccine Core Enzyme Market Trends
Table 2. mRNA Vaccine Core Enzyme Market Drivers & Opportunity
Table 3. mRNA Vaccine Core Enzyme Market Challenges
Table 4. mRNA Vaccine Core Enzyme Market Restraints
Table 5. Global mRNA Vaccine Core Enzyme Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global mRNA Vaccine Core Enzyme Revenue Market Share by Company (2020-2025)
Table 7. Global mRNA Vaccine Core Enzyme Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global mRNA Vaccine Core Enzyme Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market mRNA Vaccine Core Enzyme Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers mRNA Vaccine Core Enzyme Manufacturing Base and Headquarters
Table 11. Key Manufacturers mRNA Vaccine Core Enzyme Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of mRNA Vaccine Core Enzyme
Table 13. Global mRNA Vaccine Core Enzyme Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine Core Enzyme as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global mRNA Vaccine Core Enzyme Sales Value by Enzyme Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (2020-2025) & (US$ Million)
Table 18. Global mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (2026-2031) & (US$ Million)
Table 19. Global mRNA Vaccine Core Enzyme Sales Market Share in Value by Enzyme Type (2020-2025)
Table 20. Global mRNA Vaccine Core Enzyme Sales Market Share in Value by Enzyme Type (2026-2031)
Table 21. Global mRNA Vaccine Core Enzyme Sales Volume by Enzyme Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global mRNA Vaccine Core Enzyme Sales Volume by Enzyme Type (2020-2025) & (K Units)
Table 23. Global mRNA Vaccine Core Enzyme Sales Volume by Enzyme Type (2026-2031) & (K Units)
Table 24. Global mRNA Vaccine Core Enzyme Sales Market Share in Volume by Enzyme Type (2020-2025)
Table 25. Global mRNA Vaccine Core Enzyme Sales Market Share in Volume by Enzyme Type (2026-2031)
Table 26. Global mRNA Vaccine Core Enzyme Price by Enzyme Type (2020-2025) & (US$/Unit)
Table 27. Global mRNA Vaccine Core Enzyme Price by Enzyme Type (2026-2031) & (US$/Unit)
Table 28. Global mRNA Vaccine Core Enzyme Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global mRNA Vaccine Core Enzyme Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global mRNA Vaccine Core Enzyme Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global mRNA Vaccine Core Enzyme Sales Market Share in Value by Application (2020-2025)
Table 32. Global mRNA Vaccine Core Enzyme Sales Market Share in Value by Application (2026-2031)
Table 33. Global mRNA Vaccine Core Enzyme Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global mRNA Vaccine Core Enzyme Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global mRNA Vaccine Core Enzyme Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global mRNA Vaccine Core Enzyme Sales Market Share in Volume by Application (2020-2025)
Table 37. Global mRNA Vaccine Core Enzyme Sales Market Share in Volume by Application (2026-2031)
Table 38. Global mRNA Vaccine Core Enzyme Price by Application (2020-2025) & (US$/Unit)
Table 39. Global mRNA Vaccine Core Enzyme Price by Application (2026-2031) & (US$/Unit)
Table 40. Global mRNA Vaccine Core Enzyme Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global mRNA Vaccine Core Enzyme Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global mRNA Vaccine Core Enzyme Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global mRNA Vaccine Core Enzyme Sales Value by Region (2020-2025) & (%)
Table 44. Global mRNA Vaccine Core Enzyme Sales Value by Region (2026-2031) & (%)
Table 45. Global mRNA Vaccine Core Enzyme Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global mRNA Vaccine Core Enzyme Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global mRNA Vaccine Core Enzyme Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global mRNA Vaccine Core Enzyme Sales Volume by Region (2020-2025) & (%)
Table 49. Global mRNA Vaccine Core Enzyme Sales Volume by Region (2026-2031) & (%)
Table 50. Global mRNA Vaccine Core Enzyme Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global mRNA Vaccine Core Enzyme Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions mRNA Vaccine Core Enzyme Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions mRNA Vaccine Core Enzyme Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions mRNA Vaccine Core Enzyme Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions mRNA Vaccine Core Enzyme Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions mRNA Vaccine Core Enzyme Sales Volume, (2026-2031) & (K Units)
Table 57. Thermo Fisher Company Information
Table 58. Thermo Fisher Introduction and Business Overview
Table 59. Thermo Fisher mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Thermo Fisher mRNA Vaccine Core Enzyme Product Offerings
Table 61. Thermo Fisher Recent Development
Table 62. NEB Company Information
Table 63. NEB Introduction and Business Overview
Table 64. NEB mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. NEB mRNA Vaccine Core Enzyme Product Offerings
Table 66. NEB Recent Development
Table 67. TriLink Bio Technologies Company Information
Table 68. TriLink Bio Technologies Introduction and Business Overview
Table 69. TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. TriLink Bio Technologies mRNA Vaccine Core Enzyme Product Offerings
Table 71. TriLink Bio Technologies Recent Development
Table 72. Merck Company Information
Table 73. Merck Introduction and Business Overview
Table 74. Merck mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Merck mRNA Vaccine Core Enzyme Product Offerings
Table 76. Merck Recent Development
Table 77. Aldevron Company Information
Table 78. Aldevron Introduction and Business Overview
Table 79. Aldevron mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Aldevron mRNA Vaccine Core Enzyme Product Offerings
Table 81. Aldevron Recent Development
Table 82. Qiagen N.V. Company Information
Table 83. Qiagen N.V. Introduction and Business Overview
Table 84. Qiagen N.V. mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Qiagen N.V. mRNA Vaccine Core Enzyme Product Offerings
Table 86. Qiagen N.V. Recent Development
Table 87. Promega Company Information
Table 88. Promega Introduction and Business Overview
Table 89. Promega mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Promega mRNA Vaccine Core Enzyme Product Offerings
Table 91. Promega Recent Development
Table 92. Roche CustomBiotech Company Information
Table 93. Roche CustomBiotech Introduction and Business Overview
Table 94. Roche CustomBiotech mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Roche CustomBiotech mRNA Vaccine Core Enzyme Product Offerings
Table 96. Roche CustomBiotech Recent Development
Table 97. Takara Bio Inc. Company Information
Table 98. Takara Bio Inc. Introduction and Business Overview
Table 99. Takara Bio Inc. mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Takara Bio Inc. mRNA Vaccine Core Enzyme Product Offerings
Table 101. Takara Bio Inc. Recent Development
Table 102. Novoprotein Company Information
Table 103. Novoprotein Introduction and Business Overview
Table 104. Novoprotein mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Novoprotein mRNA Vaccine Core Enzyme Product Offerings
Table 106. Novoprotein Recent Development
Table 107. Vazyme Company Information
Table 108. Vazyme Introduction and Business Overview
Table 109. Vazyme mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Vazyme mRNA Vaccine Core Enzyme Product Offerings
Table 111. Vazyme Recent Development
Table 112. Hongene Biotech Corporatio Company Information
Table 113. Hongene Biotech Corporatio Introduction and Business Overview
Table 114. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product Offerings
Table 116. Hongene Biotech Corporatio Recent Development
Table 117. Yeasen Biotechnology Company Information
Table 118. Yeasen Biotechnology Introduction and Business Overview
Table 119. Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Yeasen Biotechnology mRNA Vaccine Core Enzyme Product Offerings
Table 121. Yeasen Biotechnology Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. mRNA Vaccine Core Enzyme Downstream Customers
Table 125. mRNA Vaccine Core Enzyme Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Vaccine Core Enzyme Product Picture
Figure 2. Global mRNA Vaccine Core Enzyme Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global mRNA Vaccine Core Enzyme Sales Value (2020-2031) & (US$ Million)
Figure 4. Global mRNA Vaccine Core Enzyme Sales Volume (2020-2031) & (K Units)
Figure 5. Global mRNA Vaccine Core Enzyme Sales Price (2020-2031) & (US$/Unit)
Figure 6. mRNA Vaccine Core Enzyme Report Years Considered
Figure 7. Global mRNA Vaccine Core Enzyme Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global mRNA Vaccine Core Enzyme Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by mRNA Vaccine Core Enzyme Revenue in 2024
Figure 10. mRNA Vaccine Core Enzyme Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Capping Enzyme Picture
Figure 12. 2'-O-Methyltransferase Picture
Figure 13. Inorganic Pyrophosphatase Picture
Figure 14. Poly (A) Polymerase Picture
Figure 15. Rnase Inhibitor Picture
Figure 16. RNA Polymerase Picture
Figure 17. Restriction Enzyme Picture
Figure 18. Dnase I Picture
Figure 19. Others Picture
Figure 20. Global mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global mRNA Vaccine Core Enzyme Sales Value Market Share by Enzyme Type, 2024 & 2031
Figure 22. Global mRNA Vaccine Core Enzyme Sales Volume by Enzyme Type (2020 VS 2024 VS 2031) & (K Units)
Figure 23. Global mRNA Vaccine Core Enzyme Sales Volume Market Share by Enzyme Type, 2024 & 2031
Figure 24. Global mRNA Vaccine Core Enzyme Price by Enzyme Type (2020-2031) & (US$/Unit)
Figure 25. Product Picture of Biopharmaceutical Companies
Figure 26. Product Picture of Academic and Research Institutions
Figure 27. Global mRNA Vaccine Core Enzyme Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 28. Global mRNA Vaccine Core Enzyme Sales Value Market Share by Application, 2024 & 2031
Figure 29. Global mRNA Vaccine Core Enzyme Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 30. Global mRNA Vaccine Core Enzyme Sales Volume Market Share by Application, 2024 & 2031
Figure 31. Global mRNA Vaccine Core Enzyme Price by Application (2020-2031) & (US$/Unit)
Figure 32. North America mRNA Vaccine Core Enzyme Sales Value (2020-2031) & (US$ Million)
Figure 33. North America mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
Figure 34. Europe mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 35. Europe mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
Figure 36. Asia Pacific mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 37. Asia Pacific mRNA Vaccine Core Enzyme Sales Value by Region (%), 2024 VS 2031
Figure 38. South America mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 39. South America mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
Figure 40. Middle East & Africa mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
Figure 42. Key Countries/Regions mRNA Vaccine Core Enzyme Sales Value (%), (2020-2031)
Figure 43. Key Countries/Regions mRNA Vaccine Core Enzyme Sales Volume (%), (2020-2031)
Figure 44. United States mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 45. United States mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
Figure 46. United States mRNA Vaccine Core Enzyme Sales Value by Application (%), 2024 VS 2031
Figure 47. Europe mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 48. Europe mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
Figure 49. Europe mRNA Vaccine Core Enzyme Sales Value by Application (%), 2024 VS 2031
Figure 50. China mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 51. China mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
Figure 52. China mRNA Vaccine Core Enzyme Sales Value by Application (%), 2024 VS 2031
Figure 53. Japan mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 54. Japan mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
Figure 55. Japan mRNA Vaccine Core Enzyme Sales Value by Application (%), 2024 VS 2031
Figure 56. South Korea mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 57. South Korea mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
Figure 58. South Korea mRNA Vaccine Core Enzyme Sales Value by Application (%), 2024 VS 2031
Figure 59. Southeast Asia mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 60. Southeast Asia mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
Figure 61. Southeast Asia mRNA Vaccine Core Enzyme Sales Value by Application (%), 2024 VS 2031
Figure 62. India mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 63. India mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
Figure 64. India mRNA Vaccine Core Enzyme Sales Value by Application (%), 2024 VS 2031
Figure 65. mRNA Vaccine Core Enzyme Industrial Chain
Figure 66. mRNA Vaccine Core Enzyme Manufacturing Cost Structure
Figure 67. Channels of Distribution (Direct Sales, and Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. mRNA Vaccine Core Enzyme Market Trends
Table 2. mRNA Vaccine Core Enzyme Market Drivers & Opportunity
Table 3. mRNA Vaccine Core Enzyme Market Challenges
Table 4. mRNA Vaccine Core Enzyme Market Restraints
Table 5. Global mRNA Vaccine Core Enzyme Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global mRNA Vaccine Core Enzyme Revenue Market Share by Company (2020-2025)
Table 7. Global mRNA Vaccine Core Enzyme Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global mRNA Vaccine Core Enzyme Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market mRNA Vaccine Core Enzyme Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers mRNA Vaccine Core Enzyme Manufacturing Base and Headquarters
Table 11. Key Manufacturers mRNA Vaccine Core Enzyme Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of mRNA Vaccine Core Enzyme
Table 13. Global mRNA Vaccine Core Enzyme Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine Core Enzyme as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global mRNA Vaccine Core Enzyme Sales Value by Enzyme Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (2020-2025) & (US$ Million)
Table 18. Global mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (2026-2031) & (US$ Million)
Table 19. Global mRNA Vaccine Core Enzyme Sales Market Share in Value by Enzyme Type (2020-2025)
Table 20. Global mRNA Vaccine Core Enzyme Sales Market Share in Value by Enzyme Type (2026-2031)
Table 21. Global mRNA Vaccine Core Enzyme Sales Volume by Enzyme Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global mRNA Vaccine Core Enzyme Sales Volume by Enzyme Type (2020-2025) & (K Units)
Table 23. Global mRNA Vaccine Core Enzyme Sales Volume by Enzyme Type (2026-2031) & (K Units)
Table 24. Global mRNA Vaccine Core Enzyme Sales Market Share in Volume by Enzyme Type (2020-2025)
Table 25. Global mRNA Vaccine Core Enzyme Sales Market Share in Volume by Enzyme Type (2026-2031)
Table 26. Global mRNA Vaccine Core Enzyme Price by Enzyme Type (2020-2025) & (US$/Unit)
Table 27. Global mRNA Vaccine Core Enzyme Price by Enzyme Type (2026-2031) & (US$/Unit)
Table 28. Global mRNA Vaccine Core Enzyme Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global mRNA Vaccine Core Enzyme Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global mRNA Vaccine Core Enzyme Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global mRNA Vaccine Core Enzyme Sales Market Share in Value by Application (2020-2025)
Table 32. Global mRNA Vaccine Core Enzyme Sales Market Share in Value by Application (2026-2031)
Table 33. Global mRNA Vaccine Core Enzyme Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global mRNA Vaccine Core Enzyme Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global mRNA Vaccine Core Enzyme Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global mRNA Vaccine Core Enzyme Sales Market Share in Volume by Application (2020-2025)
Table 37. Global mRNA Vaccine Core Enzyme Sales Market Share in Volume by Application (2026-2031)
Table 38. Global mRNA Vaccine Core Enzyme Price by Application (2020-2025) & (US$/Unit)
Table 39. Global mRNA Vaccine Core Enzyme Price by Application (2026-2031) & (US$/Unit)
Table 40. Global mRNA Vaccine Core Enzyme Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global mRNA Vaccine Core Enzyme Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global mRNA Vaccine Core Enzyme Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global mRNA Vaccine Core Enzyme Sales Value by Region (2020-2025) & (%)
Table 44. Global mRNA Vaccine Core Enzyme Sales Value by Region (2026-2031) & (%)
Table 45. Global mRNA Vaccine Core Enzyme Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global mRNA Vaccine Core Enzyme Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global mRNA Vaccine Core Enzyme Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global mRNA Vaccine Core Enzyme Sales Volume by Region (2020-2025) & (%)
Table 49. Global mRNA Vaccine Core Enzyme Sales Volume by Region (2026-2031) & (%)
Table 50. Global mRNA Vaccine Core Enzyme Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global mRNA Vaccine Core Enzyme Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions mRNA Vaccine Core Enzyme Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions mRNA Vaccine Core Enzyme Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions mRNA Vaccine Core Enzyme Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions mRNA Vaccine Core Enzyme Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions mRNA Vaccine Core Enzyme Sales Volume, (2026-2031) & (K Units)
Table 57. Thermo Fisher Company Information
Table 58. Thermo Fisher Introduction and Business Overview
Table 59. Thermo Fisher mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Thermo Fisher mRNA Vaccine Core Enzyme Product Offerings
Table 61. Thermo Fisher Recent Development
Table 62. NEB Company Information
Table 63. NEB Introduction and Business Overview
Table 64. NEB mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. NEB mRNA Vaccine Core Enzyme Product Offerings
Table 66. NEB Recent Development
Table 67. TriLink Bio Technologies Company Information
Table 68. TriLink Bio Technologies Introduction and Business Overview
Table 69. TriLink Bio Technologies mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. TriLink Bio Technologies mRNA Vaccine Core Enzyme Product Offerings
Table 71. TriLink Bio Technologies Recent Development
Table 72. Merck Company Information
Table 73. Merck Introduction and Business Overview
Table 74. Merck mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Merck mRNA Vaccine Core Enzyme Product Offerings
Table 76. Merck Recent Development
Table 77. Aldevron Company Information
Table 78. Aldevron Introduction and Business Overview
Table 79. Aldevron mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Aldevron mRNA Vaccine Core Enzyme Product Offerings
Table 81. Aldevron Recent Development
Table 82. Qiagen N.V. Company Information
Table 83. Qiagen N.V. Introduction and Business Overview
Table 84. Qiagen N.V. mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Qiagen N.V. mRNA Vaccine Core Enzyme Product Offerings
Table 86. Qiagen N.V. Recent Development
Table 87. Promega Company Information
Table 88. Promega Introduction and Business Overview
Table 89. Promega mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Promega mRNA Vaccine Core Enzyme Product Offerings
Table 91. Promega Recent Development
Table 92. Roche CustomBiotech Company Information
Table 93. Roche CustomBiotech Introduction and Business Overview
Table 94. Roche CustomBiotech mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Roche CustomBiotech mRNA Vaccine Core Enzyme Product Offerings
Table 96. Roche CustomBiotech Recent Development
Table 97. Takara Bio Inc. Company Information
Table 98. Takara Bio Inc. Introduction and Business Overview
Table 99. Takara Bio Inc. mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Takara Bio Inc. mRNA Vaccine Core Enzyme Product Offerings
Table 101. Takara Bio Inc. Recent Development
Table 102. Novoprotein Company Information
Table 103. Novoprotein Introduction and Business Overview
Table 104. Novoprotein mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Novoprotein mRNA Vaccine Core Enzyme Product Offerings
Table 106. Novoprotein Recent Development
Table 107. Vazyme Company Information
Table 108. Vazyme Introduction and Business Overview
Table 109. Vazyme mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. Vazyme mRNA Vaccine Core Enzyme Product Offerings
Table 111. Vazyme Recent Development
Table 112. Hongene Biotech Corporatio Company Information
Table 113. Hongene Biotech Corporatio Introduction and Business Overview
Table 114. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product Offerings
Table 116. Hongene Biotech Corporatio Recent Development
Table 117. Yeasen Biotechnology Company Information
Table 118. Yeasen Biotechnology Introduction and Business Overview
Table 119. Yeasen Biotechnology mRNA Vaccine Core Enzyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Yeasen Biotechnology mRNA Vaccine Core Enzyme Product Offerings
Table 121. Yeasen Biotechnology Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. mRNA Vaccine Core Enzyme Downstream Customers
Table 125. mRNA Vaccine Core Enzyme Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Vaccine Core Enzyme Product Picture
Figure 2. Global mRNA Vaccine Core Enzyme Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global mRNA Vaccine Core Enzyme Sales Value (2020-2031) & (US$ Million)
Figure 4. Global mRNA Vaccine Core Enzyme Sales Volume (2020-2031) & (K Units)
Figure 5. Global mRNA Vaccine Core Enzyme Sales Price (2020-2031) & (US$/Unit)
Figure 6. mRNA Vaccine Core Enzyme Report Years Considered
Figure 7. Global mRNA Vaccine Core Enzyme Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global mRNA Vaccine Core Enzyme Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by mRNA Vaccine Core Enzyme Revenue in 2024
Figure 10. mRNA Vaccine Core Enzyme Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Capping Enzyme Picture
Figure 12. 2'-O-Methyltransferase Picture
Figure 13. Inorganic Pyrophosphatase Picture
Figure 14. Poly (A) Polymerase Picture
Figure 15. Rnase Inhibitor Picture
Figure 16. RNA Polymerase Picture
Figure 17. Restriction Enzyme Picture
Figure 18. Dnase I Picture
Figure 19. Others Picture
Figure 20. Global mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global mRNA Vaccine Core Enzyme Sales Value Market Share by Enzyme Type, 2024 & 2031
Figure 22. Global mRNA Vaccine Core Enzyme Sales Volume by Enzyme Type (2020 VS 2024 VS 2031) & (K Units)
Figure 23. Global mRNA Vaccine Core Enzyme Sales Volume Market Share by Enzyme Type, 2024 & 2031
Figure 24. Global mRNA Vaccine Core Enzyme Price by Enzyme Type (2020-2031) & (US$/Unit)
Figure 25. Product Picture of Biopharmaceutical Companies
Figure 26. Product Picture of Academic and Research Institutions
Figure 27. Global mRNA Vaccine Core Enzyme Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 28. Global mRNA Vaccine Core Enzyme Sales Value Market Share by Application, 2024 & 2031
Figure 29. Global mRNA Vaccine Core Enzyme Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 30. Global mRNA Vaccine Core Enzyme Sales Volume Market Share by Application, 2024 & 2031
Figure 31. Global mRNA Vaccine Core Enzyme Price by Application (2020-2031) & (US$/Unit)
Figure 32. North America mRNA Vaccine Core Enzyme Sales Value (2020-2031) & (US$ Million)
Figure 33. North America mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
Figure 34. Europe mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 35. Europe mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
Figure 36. Asia Pacific mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 37. Asia Pacific mRNA Vaccine Core Enzyme Sales Value by Region (%), 2024 VS 2031
Figure 38. South America mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 39. South America mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
Figure 40. Middle East & Africa mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa mRNA Vaccine Core Enzyme Sales Value by Country (%), 2024 VS 2031
Figure 42. Key Countries/Regions mRNA Vaccine Core Enzyme Sales Value (%), (2020-2031)
Figure 43. Key Countries/Regions mRNA Vaccine Core Enzyme Sales Volume (%), (2020-2031)
Figure 44. United States mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 45. United States mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
Figure 46. United States mRNA Vaccine Core Enzyme Sales Value by Application (%), 2024 VS 2031
Figure 47. Europe mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 48. Europe mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
Figure 49. Europe mRNA Vaccine Core Enzyme Sales Value by Application (%), 2024 VS 2031
Figure 50. China mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 51. China mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
Figure 52. China mRNA Vaccine Core Enzyme Sales Value by Application (%), 2024 VS 2031
Figure 53. Japan mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 54. Japan mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
Figure 55. Japan mRNA Vaccine Core Enzyme Sales Value by Application (%), 2024 VS 2031
Figure 56. South Korea mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 57. South Korea mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
Figure 58. South Korea mRNA Vaccine Core Enzyme Sales Value by Application (%), 2024 VS 2031
Figure 59. Southeast Asia mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 60. Southeast Asia mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
Figure 61. Southeast Asia mRNA Vaccine Core Enzyme Sales Value by Application (%), 2024 VS 2031
Figure 62. India mRNA Vaccine Core Enzyme Sales Value, (2020-2031) & (US$ Million)
Figure 63. India mRNA Vaccine Core Enzyme Sales Value by Enzyme Type (%), 2024 VS 2031
Figure 64. India mRNA Vaccine Core Enzyme Sales Value by Application (%), 2024 VS 2031
Figure 65. mRNA Vaccine Core Enzyme Industrial Chain
Figure 66. mRNA Vaccine Core Enzyme Manufacturing Cost Structure
Figure 67. Channels of Distribution (Direct Sales, and Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232